Abstract
We examined the different vasodilatory effects of the K+ channel openers levcromakalim and 5-amino-N2-[2-(2-chlorophenyl)ethyl]-N′-cyano-3-pyridinecarboxamidine (KRN4884), and the Ca2+ channel blocker nifedipine in the rat aorta. KRN4884 (10−10-10−5 M) and nifedipine (10−10−10−5 M) produced concentration-dependent relaxation in the rat aorta precontracted by 25 mM KCl. The K+ channel blocker glibenclamide (1 μM) inhibited the relaxation induced by KRN4884 but did not influence nifedipine-induced relaxation. KRN 4884 had almost no effect on contraction induced by 80 mM KCl, whereas nifedipine completely relaxed the muscle precontracted by 80 mM KCl, whereas nifedipine completely relaxed the muscle precontracted by 80 mM KCl. These results indicate that KRN4884 is a K+ channel opener. We investigated the relaxant effects of KRN4884 (10−10-10−5 M), levcromakalim (10−9-10−5 M) and nifedipine (10−9-10−5 M) on A23187 (1 μM)-induced contraction. KRN4884 and levcromakalim had a potent relaxant effect but nifedipine only a weak effect on the smooth muscle contracted by A23187. Glibenclamide (1 μM) inhibited the relaxation induced by KRN4884 and levcromakalim, but did not influence the nifedipine-induced relaxation. KRN 4884 (1 μM) produced a larger relaxation of A23187-induced contraction but had little effect on the increase in intracellular [Ca2+] induced by A23187. These results suggest that KRN4884 is a specific K+ channel opener and its vasodilating mechanisms involve not only deactivation of Ca2+ channels but also a decrease in the Ca2+ sensitivity of contractile elements.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Asano T, Hidaka H (1984) Vasodilatory action of HA 1004 [N-(2-guanidinoethyl)-5-isoquinolinesulfonamide], a novel calcium antagonist with no effect on cardiac function. J Pharmacol Exp Ther 231:241–245
Best L, Bolton TB (1986) Depolarisation of guinea-pig visceral smooth muscle causes hydrolysis of inositol phospholipids. Naunyn-Schmiedeberg's Arch Pharmacol 333:78–82
Bray KM, Weston AH, Duty S, Newgreen DT, Longmore J, Edwards G, Brown T (1991) Differences between the effects of cromakalim and nifedipine on agonist-induced responses in rabbit aorta. Br J Pharmacol 102:337–344
Buckingham RE, Hamilton TC, Howlett DR, Mootoo S, Wilson C (1989) Inhibition by glibenclamide of the vasorelaxant action of cromakalim in the rat. Br J Pharmacol 97:57–64
Chin PJS, Tetzloff G, Alm H-S, Sybertz EJ (1988) Effects of BRL34915, a putative K channel opener, on transmembrane 45Ca movements in rabbit aortic smooth muscle. Eur J Pharmacol 155:229–237
Chopra LC, Charles HCT, Jeremy PTW (1992) Direct action of BRL38227 and glibenclarnide on intracellular calcium stores in cultured airway smooth muscle of rabbit. Br J Pharmacol 105:259–260
Cook NS, Weir SW, Danzeisen MC (1988) Anti-vasoconstrictor effects of the K+ channel opener cromakalim on the rabbit aorta: comparison with the calcium antagonist isradipine. Br J Pharmacol 95:741–752
Eltze M (1989) Glibenclamide is a competitive antagonist of cromakalim, pinacidil and RP 49356 in guinea-pig pulmonary artery. Eur J Pharmacol 165:231–239
Furukawa K, Itob T, Kajiwara M, Kitamura K, Suzuki H, Ito Y, Kuriyama H (1981) Vasodilating actions of 2-nicotinamidoethyl nitrate on porcine and guinea-pig coronary arteries. J Pharmacol Exp Ther 218:248–259
Ganitkevich VY, Isenberg G (1993) Membrane potential modulates inositol 1,4,5-trisphosphate-mediated Ca2+ transients in guinea-pig coronary myocytes. J Physiol (Lond) 470:35–44
Hamilton TC, Weir SW, Weston AH (1986) Comparison of the effects of BRL 34915 and verapamil on electrical and mechanical activity in rat portal vein. Br J Pharmacol 88:103–111
Ito S, Kajikuri J, Itoh T, Kuriyama H (1991) Effects of lemakalim on changes in Ca2+ concentration and mechanical activity induced by noradrenaline in the rabbit mesenteric artery. Br J Pharmacol 104:227–233
Izumi H, Jinno Y Kaneta S, Tanaka Y, Okada Y, Izawa T, Ogawa M (1995) Effect of KRN488, a novel K channel opener, on the cardiovascular system in anesthetized dogs: A comparison with levcromakalim, nilvadipine, and nifedipine. J Cardiovasc Pharmacol 26:189–197
IzumiH, Tanaka Y, Okada Y, Ogawa M, Izawa T (1996) Structure-activity relationship of a novel K+ channel opener, KRN4884, and related compounds in porcine coronary artery. Gen Pharmacol (in press)
Jinno Y, Kasai H, Ohta H, Nishikori K, Fukushima H, Ogawa N (1992) Contribution of cyclic GMP formation to KRN2391-induced relaxation in coronary artery of the pig. Br J Pharmacol 106:906–909
Kühberger E, Kukovetz WR, Groschner K (1993) Cromakalim inhibits multiple mechanisms of smooth muscle activation with similar stereoselectivity. J Cardiovasc Pharmacol 21:947–954
Mori T, Yanagisawa T, Taira N (1990) Phorbol 12,13-dibutyrate increases vascular tone but has a dual action on intracellular calcium levels in porcine coronary arteries. Naunyn-Schmiedeberg's Arch Pharmacol 341:251–255
Murray JJ, Reed PW, Fay FS (1975) Contraction of isolated smooth muscle cells by ionophore A23187. Proc Natl Acad Sci USA 72:4459–4463
Nishimura J, Van Breemen C (1989) Direct regulation of smooth muscle contractile elements by second messengers. Biochem Biophys Res Commun 163:929–935
Okada Y, Yanagisawa T, Taira N (1992a) E4080 has a dual action, as a K+ channel opener and a Ca2+ channel blocker, in canine coronary arterial smooth muscle. Eur J Pharmacol 218:259–264
Okada Y, Yanagisawa T, Taira N (1992b) KCl depolarization potentiates the Ca+ sensitization by endothelin-1 in canine coronary artery. Jpn J Pharmacol 60:403–405
Okada Y, Yanagisawa T, Yamagishi T, Taira N (1993 a) K+ channel-opening action and KRN2391-induced reduction of Ca2+ sensitivity of arterial smooth muscle. Arch Int Pharmacodyn Ther 326:33–51
Okada Y, Yanagisawa T, Taira N (1993b) BRL-38227 (levcromakalim)-induced hyperlarization reduces the sensitivity of contractile elements to Ca2+ in canine coronary artery. Naunyn-Schmiedeberg's Arch Pharmacol 347:438–444
Okada Y, Yokoyama T, Jinno Y, Kashiwabara T, Izawa T, Fukushima H, Ogawa N (1993c) Vasorelaxant action of Ki 1769, a new pyridinecarboximidamide, in isolated porcine coronary artery. Eur J Pharmacol 241:177–181
Parker RB, Waud DR (1971) Pharmacological estimation of drug-receptor dissociation constants. Statistical evaluation. I. Agonists. J Pharmacol Exp Ther 177:1–12
Quast U (1993) Do the K+ channel openers relax smooth muscle by opening K+ channels? Trends Pharmacol Sci 14:332–337
Quast U, Baumlin Y (1991) Cromakalim inhibits contractions of the rat isolated mesenteric bed induced by noradrenaline but not caffeine in Ca2+-free medium: evidence for interference with receptor-mediated Ca2+ mobilization. Eur J Pharmacol 200:239–249
Quast U, Cook NS (1989) In vitro and in vivo comparison of two K+ channel openers, diazoxide and cromakalim, and their inhibition by glibenclamide. J Pharmacol Exp Ther 250:261–271
Rasmussen H, Takuwa Y, Park S (1987) Protein kinase C in the regulation of smooth muscle contraction. FASEB J 1:177–185
Rembold CM (1992) Regulation of contraction and relaxation in arterial smooth muscle. Hypertension 20:129–137
Ruzycky AL, Morgan KG (1989) Involvement of the protein kinase C system in calcium-force relationships in ferret aorta. Br J Pharmacol 97:391–400
Thoa NB, Costa JL, Moss J, Kopin IJ (1974) Mechanism or release of norepinephrine from peripheral adrenergic neurons by the calcium ionophores X-537A and A23187. Life Sci 14:1705–1719
Triggle CR, Grant WF, Triggle DJ (1975) Intestinal smooth muscle contraction and the effects of cadmium and A23187. J Pharmacol Exp Ther 194:182–190
Weir SW, Weston AH (1986) The effects of BRL34915 and nicorandil on electrical and mechanical activity and on 86Rb efflux in rat blood vessels. Br J Pharmacol 88:121–128
Wilson C, Cooper SM (1989) Effect of cromakalim on contraction in rabbit isolated renal artery in the presence and absence of extracellular Ca2+. Br J Pharmacol 98:1303–1311
Winquist RJ, Heaney LA, Wallace AA, Baskin EP, Stein RB, Garcia ML, Kaczorowski GJ (1989) Glyburide blocks the relaxation response to BRL 34915 (cromakalim), minoxidil sulfate and diazoxide in vascular smooth muscle. J Pharmacol Exp Ther 248:149–156
Yamagishi T, Yanagisawa T, Taira N (1992a) Activation of phospholipase C by the agonist U46619 is inhibite by cromakalim-induced hyperpolarization in porcine coronary artery. Biochem Biophys Res Commun 187:1517–1522
Yamagishi T, Yanagisawa T, Taira N (1992b) K+ channel openers, cromakalim and Ki4032, inhibit agonist-induced Ca2+ release in canine coronary artery. Naunyn-Schmiedeberg's Arch Pharmacol 346:691–700
Yanagisawa T, Kawada M, Taira N (1989) Nitroglycerin relaxes canine coronary arterial smooth muscle without reducing intracellular Ca2+ concentrations measured with fura-2. Br J Pharmacol 98:469–482
Yanagisawa T, Okada Y (1993) The structure-activity relationship of KRN2391 as an N-K hybrid. Cardiovasc Drugs Rev 11:94–115
Yanagisawa T, Okada Y (1994) KCl depolarization increases Ca2+ sensitivity of contractile elements in coronary arterial smooth muscle. Am J Physiol 267:H614-H621
Yanagisawa T, Taira N (1980) Effect of 2-nicotinamidethyl nitrate (SG-75) on the membrane potential of left atrial muscle fibres of the dog. Increase in potassium conductance. Naunyn-Schmiedeberg's Arch Pharmacol 312:69–76
Yokoyama T, Kasai H, Okada Y Izumi H, Izawa T, Ogawa N (1995) Effect of Ki 1769, a novel K+-channel opener, on sensitivity to Ca2+ of contractile elements and inositol phosphate formation in porcine coronary artery. J Pharm Pharmacol 47:148–151
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kawahara, Ji., Izumi, H., Okada, Y. et al. Effects of the potassium channel openers KRN4884 and levcromakalim on the contraction of rat aorta induced by A23187, compared with nifedipine. Naunyn-Schmiedeberg's Arch Pharmacol 354, 460–465 (1996). https://doi.org/10.1007/BF00168437
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00168437